Molecular imaging biomarkers for immune checkpoint inhibitor therapy

Immune checkpoint inhibitors (ICIs) have substantially changed the field of oncology over the past few years. ICIs offer an alternative treatment strategy by exploiting the patients' immune system, resulting in a T cell mediated anti-tumor response. These therapies are effective in multiple dif...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Theranostics
Päätekijät: van de Donk, Pim P, Kist de Ruijter, Laura, Lub-de Hooge, Marjolijn N, Brouwers, Adrienne H, van der Wekken, Anthonie J, Oosting, Sjoukje F, Fehrmann, Rudolf SN, de Groot, Derk Jan A, de Vries, Elisabeth GE
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ivyspring International Publisher 2020
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6993216/
https://ncbi.nlm.nih.gov/pubmed/32042331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.38339
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia